Six short videos spotlight lessons learned at PrEP demonstration projects run by LVCT Health in Kenya. The series explores key issues from the introduction of PrEP and managing symptoms to adherence and the role of support groups.
Video Series: Lessons from the Field
Prevention Paradigm, 2017-beyond
While several different interventions exist for contraception, there aren’t yet a full array of options for HIV prevention. Choices matter. This graphic appears in AVAC Report 2017: Mixed messages and how to untangle them.
The UNAIDS 10-Point Plan for Making Progress on Prevention
The UNAIDS 10-point plan for making progress on prevention omits elements of the “research-to-rollout” continuum, and leaves the definition of prevention out—focusing on the “how” rather than the “what”. This graphic appears in AVAC Report 2017: Mixed messages and how to untangle them.
Fighting HIV Drug Resistance in Uganda
AVAC Fellow Moses Supercharger has this primer on the upward trend of HIV drug resistance in Uganda, with action items for advocates.
PrEP 101 Presentation from US Women & PrEP Working Group
Created by the US Women and PrEP Working Group, this PowerPoint is intended to help make quality, basic presentations on PrEP to community members.
Layers of Biomedical HIV Prevention Trial Stakeholders
Various stakeholders may influence or be affected by a biomedical HIV prevention trial. Stakeholders include trial participants and other community stakeholders as well as a broader range of national and international stakeholders.
Excerpted from the Good Participatory Practice (GPP) Guidelines, which provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with all stakeholders in the design and conduct of biomedical HIV prevention trials. More at avac.org/gpp.
PrEP for MSM in Africa: Meeting Summary and Next Steps
Advocates gather in South Africa for the continent’s first PrEP and MSM consultation to chart a path for PrEP access. See the report summary with links to presentations and country plans.
Biomedical Prevention in 2016 – At a Glance
A snapshot of prevention strategies underway or under development from 2015-2020. Excerpted from AVAC Report 2016: Big Data, Real People.
Gender Binaries and Competition for Resources
In the past year, as focus has rightly been placed on the needs of adolescent girls and young women, some stakeholders have suggested that men are being left behind. The offers a perfect example of data that prompt counterproductive action. Men aren’t being left behind. Both men and women, and boys and girls, are underserved in different ways.
This graphic was excerpted from AVAC Report 2016: Big Data, Real People.
Key Barriers to Women’s Access to HIV Treatment: Making ‘Fact-Track’ a Reality
It is essential to understand the barriers to and facilitators of women’s access to ART, so that individual choices about when and whether to start, and continue with, treatment translate into positive mental and physical health outcomes for the woman, as well as benefiting public health.
In this review, socio-structural factors were explored at macro-, meso- and micro-levels in order to better understand the experiences women living with HIV have of treatment availability and their decision-making around uptake, and to assess how treatment programmes affect their lives. Removing barriers and changing policies and programmes to align with best practices will contribute substantially to efforts for the achievement of global goals such as the ‘90-90-90’ UNAIDS ‘Fast-Track’ targets.